Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-16T06:12:18.989Z Has data issue: false hasContentIssue false

18 - Pathogen surveillance and discovery

from Section III - Introduction: immunity, diagnosis, vector, and beneficial uses of neurotropic viruses

Published online by Cambridge University Press:  22 August 2009

W. Ian Lipkin
Affiliation:
Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA
Thomas Briese
Affiliation:
Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA
Carol Shoshkes Reiss
Affiliation:
New York University
Get access

Summary

Introduction

This chapter will describe methods and perspectives for pathogen discovery and surveillance, provide vignettes from our own experience that illustrate the complexity of pursuing research in this arena and the process that led to the implementation of particular strategies, and discuss challenges associated with proving causality.

Proof of causation

Discovery of an organism in association with disease is only the first step in understanding its role in pathogenesis. Many have wrestled with the challenge of codifying the process of proving causation. The germ theory of disease formulated by Pasteur, Koch, and Loeffler proposed precise criteria that define a causative relationship between agent and disease: the agent should be present in every case of a disease, it should be specific for a disease (i.e., present in none other); it should be propagated in culture and proven capable of causing the same disease upon inoculation into a naïve host. Known as Koch's postulates [1], these criteria were subsequently modified by Rivers for specific application to viruses [2] and by Fredericks and Relman to reflect the advent of molecular methods [3] (Table 18.1). Koch's postulates remain the ideal standard by which causality is considered to be proven. However, there are problems with holding to this standard. Some agents cannot be propagated in culture. Additionally, for many human viral pathogens there may be no animal model.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Koch, R., Ueber bakteriologische Forschung, Verhandl. des X. Interna. Med. Congr., Berlin, 1890, August Hirschwald, Berlin, 1981, p. 35.Google Scholar
Rivers, T. M., J Bacteriol, 33 (1937) 1–12.
Fredricks, D. N. and Relman, D. A., Clin Microbiol Rev, 9 (1996) 18–33.
Relman, D. A., Science, 284 (1999) 1308–10.CrossRef
Challoner, P. B., Smith, K. T., Parker, J. D., et al., Proc Natl Acad Sci U S A, 92 (1995) 7440–4.CrossRef
Chang, Y., Cesarman, E., Pessin, M. S., et al., Science, 266 (1994) 1865–9.CrossRef
Choo, Q. L., Kuo, G., Weiner, A. J., et al., Science, 244 (1989) 359–62.CrossRef
Lipkin, W. I., Travis, G. H., Carbone, K. M., et al., Proc Natl Acad Sci U S A, 87 (1990) 4184–8.CrossRef
Nichol, S. T., Spiropoulou, C. F., Morzunov, S., et al., Science, 262 (1993) 914–7.CrossRef
Relman, D. A., Loutit, J. S., Schmidt, T. M., et al., N Engl J Med, 323 (1990) 1573–80.CrossRef
Relman, D. A., Schmidt, T. M., MacDermott, R. P., et al., N Engl J Med, 327 (1992) 293–301.CrossRef
VandeWoude, S., Richt, J. A., Zink, M. C., et al., Science, 250 (1990) 1278–81.CrossRef
Dalluge, J. J., Fresenius J Anal Chem, 366 (2000) 701–11.CrossRef
Baar, B. L., FEMS Microbiol Rev, 24 (2000) 193–219.CrossRef
Diehn, M. and Relman, D. A., Curr Opin Microbiol, 4 (2001) 95–101.CrossRef
Taylor, L. A., Carthy, C. M., Yang, D., et al., Circ Res, 87 (2000) 328–34.CrossRef
Zhu, H., Cong, J. P., Mamtora, G., et al., Proc Natl Acad Sci USA, 95 (1998) 14470–5.CrossRef
Hubank, M. and Schatz, D. G., Nucleic Acids Res, 22 (1994) 5640–8.CrossRef
Lisitsyn, N., Lisitsyn, N., and Wigler, M., Science, 259 (1993) 946–51.CrossRef
Liang, P. and Pardee, A. B., Science, 257 (1992) 967–71.CrossRef
Briese, T., Jia, X. Y., Huang, C., et al., Lancet, 354 (1999) 1261–2.CrossRef
Jia, X. Y., Briese, T., Jordan, I., et al., Lancet, 354 (1999) 1971–2.CrossRef
Briese, T., , Torre J. C., Lewis, A., et al., Proc Natl Acad Sci USA, 89 (1992) 11486–9.CrossRef
Briese, T., Schneemann, A., Lewis, A. J., et al., Proc Natl Acad Sci USA, 91 (1994) 4362–6.CrossRef
, Torre J. C., J Virol, 68 (1994) 7669–75.
Cubitt, B., Oldstone, C., Valcarcel, J., et al., Virus Res, 34 (1994) 69–79.CrossRef
Schneider, P. A., Schneemann, A., and Lipkin, W. I., J Virol, 68 (1994) 5007–12.
Schneemann, A., Schneider, P. A., Lamb, R. A., et al., Virology, 210 (1995) 1–8.CrossRef
Schwemmle, M., Jehle, C., Formella, S., et al., Lancet, 354 (1999) 1973–4.CrossRef
Lipkin, W. I., Hornig, M., and Briese, T., et al., Trends Microbiol, 9 (2001) 295–8.CrossRef
Asnis, D. S., Conetta, R., Teixeira, A. A., et al., Clin Infect Dis, 30 (2000) 413–8.CrossRef
Steele, K. E., Linn, M. J., Schoepp, R. J., et al., Vet Pathol, 37 (2000) 208–24.CrossRef
Lanciotti, R. S., Roehrig, J. T., Deubel, V., et al., Science, 286 (1999) 2333–7.CrossRef
Shieh, W. J., Guarner, J., Layton, M., et al., Emerg Infect Dis, 6 (2000) 370–2.CrossRef
Briese, T., Glass, W. G., and Lipkin, W. I., Lancet, 355 (2000) 1614–5.CrossRef
Centers for Disease Control, MMWR Morb Mortal Wkly Rep, 52 (2003) 769–72.
Centers for Disease Control, MMWR Morb Mortal Wkly Rep, 53 (2004) 281–4.
Berger, M. M., Kopp, N., Vital, C., et al., Neurology, 54 (2000) 20–5.CrossRef
Walker, M. P., Schlaberg, R., Hays, A. P., et al., Ann Neurol, 49 (2001) 249–53.3.0.CO;2-3>CrossRef
Coiras, M. T., Aguilar, J. C., Garcia, M. L., et al., J Med Virol, 72 (2004) 484–95.CrossRef
Ellis, J. S. and Zambon, M. C., Rev Med Virol, 12 (2002) 375–89.CrossRef
Fan, J., Henrickson, K. J., and Savatski, L. L., Clin Infect Dis, 26 (1998) 1397–402.CrossRef
Grondahl, B., Puppe, W., Hoppe, A., et al., J Clin Microbiol, 37 (1999) 1–7.
Briese, T., Palacios, G., Kokoris, M., et al., Emerg Infect Dis, 11 (2005) 310–3.CrossRef
Lamson, D., Renwick, N., Kapoor, V., et al., J Infect Dis, 194 (2006) 1398–402.CrossRef
Bailey, T. L. and Gribskov, M., Bioinformatics, 14 (1998) 48–54.CrossRef
Palacios, G., Quan, P.-L., Jabado, O., et al., Emerg Infect Dis, 13 (2007) 73–81.CrossRef

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Pathogen surveillance and discovery
    • By W. Ian Lipkin, Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA, Thomas Briese, Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA
  • Edited by Carol Shoshkes Reiss, New York University
  • Book: Neurotropic Viral Infections
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541728.023
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Pathogen surveillance and discovery
    • By W. Ian Lipkin, Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA, Thomas Briese, Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA
  • Edited by Carol Shoshkes Reiss, New York University
  • Book: Neurotropic Viral Infections
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541728.023
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Pathogen surveillance and discovery
    • By W. Ian Lipkin, Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA, Thomas Briese, Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA
  • Edited by Carol Shoshkes Reiss, New York University
  • Book: Neurotropic Viral Infections
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541728.023
Available formats
×